Infiltrating breast carcinoma in patients age 30 years and younger: Long term outcome for life, relapse, and second primary tumors

1992 ◽  
Vol 23 (5) ◽  
pp. 969-975 ◽  
Author(s):  
Catherine G. Lee ◽  
Beryl McCormick ◽  
Madhuchhanda Mazumdar ◽  
John Vetto ◽  
Patrick I. Borgen
Keyword(s):  
Breast Carcinoma ◽  
Second Primary ◽  
Term Outcome ◽  
Primary Tumors ◽  
Long Term Outcome ◽  
Second Primary Tumors

Long‐term outcome of re‐irradiation for recurrent or second primary head and neck cancer: A multi‐institutional study of AIRO—Head and Neck working group

Head & Neck ◽  
2019 ◽  
Vol 41 (10) ◽  
pp. 3684-3692 ◽  
Author(s):  
Ester Orlandi ◽  
Pierluigi Bonomo ◽  
Letizia Ferella ◽  
Elisa D'Angelo ◽  
Marta Maddalo ◽  
...  
Keyword(s):  
Head And Neck Cancer ◽  
Head And Neck ◽  
Neck Cancer ◽  
Working Group ◽  
Second Primary ◽  
Term Outcome ◽  
Long Term Outcome

Second primary tumors in laryngeal cancer: results of long-term follow-up

1998 ◽  
Vol 42 (3) ◽  
pp. 557-562 ◽  
Author(s):  
Ashwatha Narayana ◽  
AndrewT.M Vaughan ◽  
SusanG Fisher ◽  
SaradaP Reddy
Keyword(s):  
Laryngeal Cancer ◽  
Second Primary ◽  
Primary Tumors ◽  
Long Term Follow Up ◽  
Second Primary Tumors

Clinical characteristics and long-term outcome of young hairy cell leukemia patients treated with cladribine: a single-institution series

Blood ◽  
2014 ◽  
Vol 123 (2) ◽  
pp. 177-183 ◽  
Author(s):  
Joshua D. Rosenberg ◽  
Carol Burian ◽  
Jill Waalen ◽  
Alan Saven
Keyword(s):  
Hairy Cell Leukemia ◽  
Second Primary ◽  
Hairy Cell ◽  
Cell Leukemia ◽  
Term Outcome ◽  
Long Term Outcome ◽  
Increased Risk ◽  
Key Points ◽  
Second Primary Malignancies

Key Points HCL patients ≤40 years at diagnosis treated with cladribine obtain complete and durable responses, but ultimately relapse. There was no increased risk of second primary malignancies in young hairy cell leukemia patients followed for protracted periods.

Sign in / Sign up

Export Citation Format

Share Document